Publicações

Viral Surface Glycoproteins, Gp120 and Gp41, as Potential Drug Targets Against Hiv-1: Brief Overview One Quarter of a Century Past the Approval of Zidovudine, the First Anti-Retroviral Drug (Vol 46, Pg 979, 2011)

AuthID
P-002-PEW

Author(s)

Teixeira, C

Gomes, JRB

Gomes, P

Maurel, F

Barbault, F

Tipo de Documento

Correction

Year published

2011

Publicado

in EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, ISSN: 0223-5234

Volume: 46, Número: 8, Páginas: 3541-3541 (1)

Indexing

Wos^®

Scopus^®

Crossref^®

Google Scholar^®

Publication Identifiers

DOI: 10.1016/j.ejmech.2011.03.042

SCOPUS: 2-s2.0-79958269373

Wos: WOS:000292670000042

Source Identifiers

ISSN: 0223-5234

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Citações

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference

No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Full Text

Full Text @ sfx.b-on.pt

Viral Surface Glycoproteins, Gp120 and Gp41, as Potential Drug Targets Against Hiv-1: Brief Overview One Quarter of a Century Past the Approval of Zidovudine, the First Anti-Retroviral Drug (Vol 46, Pg 979, 2011)

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Viral Surface Glycoproteins, Gp120 and Gp41, as Potential Drug Targets Against Hiv-1: Brief Overview One Quarter of a Century Past the Approval of Zidovudine, the First Anti-Retroviral Drug (Vol 46, Pg 979, 2011)

Links Úteis

Ajuda